Intended for healthcare professionals

Letters Cannabinoid hyperemesis syndrome

Authors’ reply to Braillon and Bewley, Spiller and colleagues, and Wu

BMJ 2019; 366 doi: (Published 23 September 2019) Cite this as: BMJ 2019;366:l5622
  1. Julien Vaucher, consultant and senior clinical lecturer,
  2. Yaniv Chocron, chief resident
  1. Lausanne University Hospital, 1011 Lausanne, Switzerland
  1. julien.vaucher{at}

Braillon and Bewley emphasise the importance of recognising cannabinoid hyperemesis syndrome; we are pleased that our article might help patients and physicians tackle this condition.12 Our aim was not to consider any issue related to legalisation or liberalisation of cannabis. Societal or political decisions about use of cannabis …

View Full Text

Log in

Log in through your institution


* For online subscription